Studie - South Africa Diabetes Care Devices Market Outlook to 2016

South Africa Diabetes Care Devices Market Outlook to 2016

Summary

GlobalData’s medical equipment offering, 'South Africa Diabetes Care Devices Market Outlook to 2016” provides key market data on the South Africa diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories — Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for two diabetes care devices market categories — Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the South Africa diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa diabetes care devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution — Identify, understand and capitalize.

Companies mentioned:

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
Novo Nordisk A/S
Eli Lilly and Company
B. Braun Melsungen AG
Medtronic, Inc.
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 What is This Report About? 8

3 Diabetes Care Devices In South Africa 9

3.1 Diabetes Care Devices, Market Segmentation 9

3.2 Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016 10

3.3 Diabetes Care Devices Market, South Africa, Revenue Mix ($m), 2009 11

3.4 Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009 12

3.5 Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016 16

3.6 Diabetes Care Devices, South Africa, Company Share (2008-2009) 19

4 Glucose Monitoring In South Africa 20

4.1 Glucose Monitoring, Market Segmentation 20

4.2 Glucose Monitoring Market, South Africa, Revenue Mix ($m), 2009 21

4.3 Glucose Monitoring Market, South Africa, Category Contribution (%), 2009 22

4.4 Glucose Monitoring Overall Revenue (2002-2016) 23

4.5 Glucose Monitoring Overall Volume (2002-2016) 25

4.6 Glucose Monitoring Average Price (2002-2016) 27

4.7 Glucose Monitoring Distribution Share (2008-2009) 28

4.8 Glucose Monitoring, South Africa, Company Share (2008-2009) 29

5 Insulin Delivery In South Africa 30

5.1 Insulin Delivery, Market Segmentation 30

5.2 Insulin Delivery Market, South Africa, Revenue Mix ($m), 2009 31

5.3 Insulin Delivery Market, South Africa, Category Contribution (%), 2009 32

5.4 Insulin Delivery Overall Revenue (2002-2016) 33

5.4.1 Insulin Pens Revenue (2002-2016) 35

5.5 Insulin Delivery Overall Volume (2002-2016) 37

5.5.1 Insulin Pens Volume (2002-2016) 39

5.6 Insulin Delivery Average Price (2002-2016) 41

5.7 Insulin Delivery Distribution Share (2008-2009) 42

5.8 Insulin Delivery, South Africa, Company Share (2008-2009) 43

6 Overview of Key Companies in South Africa Diabetes Care Devices Market 45

6.1 F. Hoffmann-La Roche Ltd. 45

6.1.1 Company Overview 45

6.1.2 Share in the South Africa Diabetes Care Devices Market 45

6.2 Bayer HealthCare AG 46

6.2.1 Company Overview 46

6.2.2 Share in the South Africa Diabetes Care Devices Market 46

6.3 LifeScan, Inc. 47

6.3.1 Company Overview 47

6.3.2 Share in the South Africa Diabetes Care Devices Market 47

6.4 Sanofi-Aventis 48

6.4.1 Company Overview 48

6.4.2 Share in the South Africa Diabetes Care Devices Market 48

6.5 Novo Nordisk A/S 49

6.5.1 Company Overview 49

6.5.2 Share in the South Africa Diabetes Care Devices Market 49

6.6 Eli Lilly and Company 50

6.6.1 Company Overview 50

6.6.2 Share in the South Africa Diabetes Care Devices Market 50

6.7 B. Braun Melsungen AG 51

6.7.1 Company Overview 51

6.8 Medtronic, Inc. 51

6.8.1 Company Overview 51

6.9 Abbott Laboratories 52

6.9.1 Company Overview 52

6.10 Becton, Dickinson and Company 52

6.10.1 Company Overview 52

6.11 Smiths Medical 53

6.11.1 Company Overview 53

6.12 Terumo Corporation 53

6.12.1 Company Overview 53

6.13 ARKRAY, Inc. 54

6.13.1 Company Overview 54

6.14 Apex Biotechnology Corp. 54

6.14.1 Company Overview 54

6.15 Animas Corporation 54

6.15.1 Company Overview 54

7 Diabetes Care Devices Market Pipeline Products 55

8 Appendix 58

8.1 Definitions of Markets Covered in the Report 59

8.1.1 Diabetes Care Devices 59

8.2 Research Methodology 61

8.3 Secondary Research 62

8.4 Primary Research 62

8.5 Models 63

8.6 Forecasts 63

8.7 Expert Panels 63

8.8 GlobalData Consulting 63

8.9 Currency Conversion 64

8.10 Contact Us 64

8.11 Disclaimer 64



1.1 List of Tables

Table 1: Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016 10

Table 2: Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009 12

Table 3: Diabetes Care Devices, South Africa, Cross-Segment Analysis, 2002-2016 13

Table 4: Diabetes Care Devices, South Africa, Overall Revenue ($m), Historic, 2002-2009 14

Table 5: Diabetes Care Devices, South Africa, Overall Revenue ($m), Forecast, 2009-2016 15

Table 6: Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016 16

Table 7: Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2002-2009 17

Table 8: Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2009-2016 18

Table 9: Diabetes Care Devices, South Africa, Company Share by Revenue ($m), 2008-2009 19

Table 10: Glucose Monitoring Market, South Africa, Category Contribution (%), 2009 22

Table 11: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 23

Table 12: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 24

Table 13: Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2002-2009 25

Table 14: Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2009-2016 26

Table 15: Glucose Monitoring, South Africa, Average Price ($), Historic, 2002-2009 27

Table 16: Glucose Monitoring, South Africa, Average Price ($), Forecast, 2009-2016 27

Table 17: Glucose Monitoring, South Africa, Distribution Share by Revenue ($m), 2008-2009 28

Table 18: Glucose Monitoring, South Africa, Company Share by Revenue ($m), 2008-2009 29

Table 19: Insulin Delivery Market, South Africa, Category Contribution (%), 2009 32

Table 20: Insulin Delivery, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 33

Table 21: Insulin Delivery, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 34

Table 22: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35

Table 23: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36

Table 24: Insulin Delivery, South Africa, Volume (Units) by Segment, Historic, 2002-2009 37

Table 25: Insulin Delivery, South Africa, Volume (Units) by Segment, Forecast, 2009-2016 38

Table 26: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2002-2009 39

Table 27: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2009-2016 40

Table 28: Insulin Delivery, South Africa, Average Price ($), Historic, 2002-2009 41

Table 29: Insulin Delivery, South Africa, Average Price ($), Forecast, 2009-2016 41

Table 30: Insulin Delivery, South Africa, Distribution Share by Revenue ($m), 2008-2009 42

Table 31: Insulin Delivery, South Africa, Company Share by Revenue ($m), 2008-2009 44

Table 32: Diabetes Care Devices Pipeline Products 55

Table 33: USD to Local Currency, South Africa, Average Actual Rate 2002-2009 64



1.2 List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation 9

Figure 2: Diabetes Care Devices, South Africa, Overall Revenue ($m), 2002-2016 10

Figure 3: Diabetes Care Devices Market, South Africa, Revenue Mix ($m), 2009 11

Figure 4: Diabetes Care Devices Market, South Africa, Category Contribution (%), 2009 12

Figure 5: Diabetes Care Devices, South Africa, Cross-Segment Analysis, 2002-2016 13

Figure 6: Diabetes Care Devices, South Africa, Overall Revenue ($m), Historic, 2002-2009 14

Figure 7: Diabetes Care Devices, South Africa, Overall Revenue ($m), Forecast, 2009-2016 15

Figure 8: Diabetes Care Devices, South Africa, Category Volume (Units), 2002-2016 16

Figure 9: Diabetes Care Devices, South Africa, Category Volume (Units), Historic, 2002-2009 17

Figure 10: Diabetes Care Devices, South Africa, Category Volume (Units), Forecast, 2009-2016 18

Figure 11: Diabetes Care Devices, South Africa, Company Share (%), 2009 19

Figure 12: Glucose Monitoring, Market Segmentation 20

Figure 13: Glucose Monitoring Market, South Africa, Revenue Mix ($m), 2009 21

Figure 14: Glucose Monitoring Market, South Africa, Category Contribution (%), 2009 22

Figure 15: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 23

Figure 16: Glucose Monitoring, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 24

Figure 17: Glucose Monitoring, South Africa, Volume (Units) by Segment, Historic, 2002-2009 25

Figure 18: Glucose Monitoring, South Africa, Volume (Units) by Segment, Forecast, 2009-2016 26

Figure 19: Glucose Monitoring, South Africa, Company Share (%), 2009 29

Figure 20: Insulin Delivery, Market Segmentation 30

Figure 21: Insulin Delivery Market, South Africa, Revenue Mix ($m), 2009 31

Figure 22: Insulin Delivery Market, South Africa, Category Contribution (%), 2009 32

Figure 23: Insulin Delivery, South Africa, Revenue ($m) by Segment, Historic, 2002-2009 33

Figure 24: Insulin Delivery, South Africa, Revenue ($m) by Segment, Forecast, 2009-2016 34

Figure 25: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35

Figure 26: Insulin Pens, South Africa, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 36

Figure 27: Insulin Delivery, South Africa, Volume (Units) by Segment, Historic, 2002-2009 37

Figure 28: Insulin Delivery, South Africa, Volume (Units) by Segment, Forecast, 2009-2016 38

Figure 29: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Historic, 2002-2009 39

Figure 30: Insulin Pens, South Africa, Volume (Units) by Sub-Segment, Forecast, 2009-2016 40

Figure 31: Insulin Delivery, South Africa, Company Share (%), 2009 43

Figure 32: F. Hoffmann-La Roche Ltd, Company Share (%), South Africa Diabetes Care Devices Market, 2009 45

Figure 33: Bayer HealthCare AG, Company Share (%), South Africa Diabetes Care Devices Market, 2009 46

Figure 34: LifeScan, Inc., Company Share (%), South Africa Diabetes Care Devices Market, 2009 47

Figure 35: Sanofi-Aventis, Company Share (%), South Africa Diabetes Care Devices Market, 2009 48

Figure 36: Novo Nordisk A/S, Company Share (%), South Africa Diabetes Care Devices Market, 2009 49

Figure 37: Eli Lilly and Company, Company Share (%), South Africa Diabetes Care Devices Market, 2009 50

Figure 38: GlobalData Methodology 61

• Diabetes – Pipeline Review, H1 2013
• Diabetic Foot Ulcers – Pipeline Review, H1 2013
• Diabetic Nephropathy – Pipeline Review, H1 2013
• Diabetic Neuropathy – Pipeline Review, H1 2013
• Type 2 Diabetes – Pipeline Review, H1 2013
• Global Insulin Antidiabetics Market 2012-2016
• Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth
• Adult Mouth Care in Romania
• Global Diabetes Drugs Market 2011-2015
• Argentina Diabetes Care Devices Market Outlook to 2018
• Asia-Pacific Diabetes Care Devices Market Outlook to 2018
• Australia Diabetes Care Devices Market Outlook to 2018
• Austria Diabetes Care Devices Market Outlook to 2018
• Belgium Diabetes Care Devices Market Outlook to 2018
• Brazil Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
• Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
• Chile Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
• China Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
• Czech Republic Diabetes Care Devices Market Outlook to 2018
• Denmark Diabetes Care Devices Market Outlook to 2018